Skip to main content
Skip to main content
SY logo

So-Young International Inc. (SY) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$2.64 +$0.02 (+0.76%) |Weak · 34
So-Young International Inc. (SY) bottom line: signals are mixed — the Council read leans Split View (40/100) while the AI fundamental score is 34/100 (grade D); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $346M| Vol: 19K| 52-wk range: $1.28 – $4.75

Market cap $346M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

So-Young International Inc. (SY) trades at $2.64 with MoonshotScore 34/100 (Grade D). So-Young International Inc. is a leading online platform in China for medical aesthetics and consumption healthcare services, connecting users with treatment providers. Market cap: $346M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026
So-Young International Inc. is a leading online platform in China for medical aesthetics and consumption healthcare services, connecting users with treatment providers. Founded in 2013, the company focuses on discretionary medical treatments, facilitating reservations and sharing experiences in the healthcare sector.

Analyst Coverage for SY: SY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the SY film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 40/100 · C

SY: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 34/100
Business Quality
Neutral Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Neutral Is the growth real and likely to last?
Momentum
Neutral Is the market already moving on this?

Strongest side: Valuation (7/10, Moderate). Weakest side: Financial Safety (3/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

So-Young International Inc. (SY) Healthcare & Pipeline Overview

CEOXing Jin
Employees2,348
HeadquartersBeijing, CN
IPO Year2019

So-Young International Inc. operates a comprehensive online platform for medical aesthetics and healthcare services, enabling users to discover, review, and reserve treatments while connecting with a vast network of service providers in China and beyond.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for SY?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

So-Young International Inc. presents a unique investment thesis driven by its strong market position in the rapidly growing medical aesthetics sector. With a market cap of $346M, the company operates in a lucrative industry projected to expand significantly in the coming years. The company's gross margin stands at 46.0%, indicating efficient operations and strong pricing power. Key growth catalysts include the increasing demand for discretionary medical treatments in China, the expansion of its service offerings, and the growing number of healthcare providers on its platform. However, the company faces risks such as regulatory challenges and market competition, which could impact its profit margin, currently at -15.5%. Investors should closely monitor these dynamics as they assess the company's potential for future growth.

Based on FMP financials and quantitative analysis

SY Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market cap of $346M reflects the company's position in the medical aesthetics sector.

  • Gross margin of 46.0% indicates strong operational efficiency.
  • Profit margin of -15.5% highlights current challenges in profitability.
  • The platform connects approximately 8,400 medical aesthetic providers with users.
  • The company employs around 1,800 staff to support its operations.

Who Are SY's Competitors?

SY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CLOV Clover Health Investments, Corp. $4.71 +8.53% $2.44B 375-pillar
HCA HCA Healthcare, Inc. $426.98 +1.37% $92.4B 815-pillar
AMGN Amgen Inc. $382.47 -2.25% $206B 815-pillar
SLP Simulations Plus, Inc. $18.42 +0.01% $373M 805-pillar
CARL CARLSMED, INC. $14.76 -1.53% $401M 315-pillar
EVH Evolent Health, Inc $4.17 +0.48% $469M
NRC National Research Corporation $21.07 -0.89% $475M 725-pillar
SPOK Spok Holdings, Inc. $10.63 +0.57% $222M 835-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SY's Key Strengths?

Established platform with a significant user base.

  • Diverse range of services catering to various healthcare needs.
  • Strong gross margin indicating operational efficiency.

What Are SY's Weaknesses?

Negative profit margin indicating current financial challenges.

  • Heavy reliance on the Chinese market for revenue.
  • Limited brand recognition outside of China.

What Could Drive SY Stock Higher?

Expansion of service offerings into new healthcare segments.

  • Strong user engagement and content generation on the platform.
  • Potential partnerships with international healthcare providers.
  • Growth in the number of medical aesthetic service providers on the platform.
  • Introduction of telehealth services to enhance user experience.

What Are the Key Risks for SY?

Financial-distress signal — its Altman Z-Score of 1.18 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-15.9%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory changes impacting the medical aesthetics industry.
  • Intense competition from other healthcare platforms.
  • Economic downturns affecting consumer spending on discretionary treatments.
  • Fluctuations in currency exchange rates impacting ADR value.

What Are the Growth Opportunities for SY?

  • Expansion of Service Offerings: So-Young International Inc. has the opportunity to broaden its range of services beyond medical aesthetics into other healthcare segments, such as wellness and preventive care.
  • Increased Digital Engagement: With the rise of digital health solutions, So-Young can enhance its platform to include telehealth services, which are projected to grow at a CAGR of 25% over the next five years. By integrating virtual consultations and follow-up services, the company can improve user engagement and satisfaction, driving higher reservation rates.
  • Strategic Partnerships: Collaborating with leading healthcare providers and technology firms can enhance So-Young's service offerings and market reach. Partnerships could facilitate access to advanced medical technologies and innovative treatment options, positioning the company as a leader in the healthcare information services sector and potentially increasing its market share.
  • International Market Penetration: So-Young has the potential to expand its platform internationally, targeting markets with growing demand for medical aesthetics. The global medical aesthetics market is expected to reach $25 billion by 2027, providing a significant opportunity for revenue growth through international service provider partnerships and localized marketing strategies.
  • Enhanced User Experience through AI: Leveraging artificial intelligence to personalize user experiences on the platform can significantly improve customer satisfaction. By analyzing user preferences and treatment histories, So-Young can offer tailored recommendations, which may lead to increased conversion rates and higher customer retention.

What Are SY's Competitive Advantages?

  • Strong brand recognition in the medical aesthetics sector.
  • Large network of service providers enhances user choice.
  • Comprehensive platform that integrates content, reservations, and reviews.
  • Established user base with high engagement rates.
  • Expertise in the healthcare information services industry.

What Does SY Do?

Founded in 2013 and headquartered in Beijing, So-Young International Inc. has established itself as a prominent online platform in the medical aesthetics and consumption healthcare sector. The company primarily focuses on discretionary medical treatments, catering to a growing demand in the People's Republic of China and internationally. So-Young's platform allows users to explore content related to medical aesthetics, share personal experiences, and reserve treatment services from a network of over 8,400 medical aesthetic service providers and 5,000 healthcare service providers as of December 31, 2021. The platform not only facilitates reservations but also provides valuable insights into treatment trends, user ratings, and reviews through its Beauty Diaries blog. Additionally, So-Young offers a range of services including Software as a Service, consulting, and training programs for medical service providers, along with internet information and technology advisory services. The company also engages in the sale of medical equipment and microfinance services, further diversifying its revenue streams. As a leader in its field, So-Young International Inc. is well-positioned to capitalize on the increasing consumer interest in medical aesthetics and healthcare services.

What Products and Services Does SY Offer?

  • Operates an online platform for medical aesthetics and healthcare services.
  • Facilitates reservations for various medical treatments.
  • Provides content and user experiences related to medical aesthetics.
  • Offers Software as a Service for healthcare providers.
  • Conducts training and consulting services for medical service providers.
  • Sells medical equipment and offers microfinance services.

How Does SY Make Money?

  • Generates revenue through service reservations made on its platform.
  • Offers subscription-based Software as a Service for healthcare providers.
  • Provides consulting and training services for medical aesthetics professionals.
  • Sells medical equipment and related services.
  • Engages in microfinance services to support healthcare providers.

What Industry Does SY Operate In?

The medical aesthetics and healthcare information services industry is experiencing robust growth, driven by increasing consumer demand for cosmetic procedures and healthcare services. The market is characterized by a shift towards digital platforms that facilitate service reservations and enhance consumer experiences. So-Young International Inc. operates in a competitive landscape, where it differentiates itself through its comprehensive platform that not only connects users with service providers but also offers valuable content and insights. As the industry continues to evolve, companies that can effectively leverage technology and consumer engagement are well-positioned for success.

Who Are SY's Key Customers?

  • Individuals seeking medical aesthetic treatments.
  • Medical aesthetic service providers looking to attract customers.
  • Healthcare professionals seeking training and consulting services.
  • Companies in need of medical equipment and technology solutions.
  • Consumers interested in health and wellness services.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

High 85/100

Broad, current evidence sits behind this analysis.

  • Scored on 94% of our measures
  • Price is current
  • Latest filing 11 days ago
  • No analyst coverage
  • Reported in CNY, converted to USD

Why 34?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.38 Gross profit per dollar of assets (Business Quality)
  • +0.37 Enterprise value vs sales (Valuation)
  • +0.18 Return on equity (Business Quality)

What is holding it back

  • -0.48 5-year net income per share (Growth)
  • -0.30 Free cash flow growth (Growth)
  • -0.29 Volatility vs the market (Financial Strength)

Risk penalties applied

  • -0.12 Bankruptcy-risk score in the grey zone
  • -1.31 Loss-making with negative retained earnings

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 49
2026-08-26 49
2026-08-29 49
2026-09-01 34
2026-09-04 34
2026-09-07 34
2026-09-10 34

What changed?

The grade moved from 49 to 34 (-15).

Over the same 18 days the stock moved +14.4%.

Net buying

Insider Activity

Over the past six months, So-Young International Inc. insiders filed 12 SEC Form 4 transactions — 5 sales and 7 purchases. On net that is roughly 74K shares acquired (about $742) — insiders putting money in tends to read as conviction.

4/8 beats

Earnings Track Record

So-Young International Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 7.8% above estimates on average.

F-Score 3/9

Financial Health

So-Young International Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.18 places it in the distress zone, a signal of elevated financial risk.

ROE -16%

Key Financial Metrics

Return on equity for So-Young International Inc. stands at -15.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -19.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.73 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -16.9%, the inverse of the P/E and a quick read on earnings relative to price.

So-Young International Inc. (SY) Valuation Context

Valued at $346M, SY is classified as a small-cap stock. Relative to its peer group, SY's quantitative score of 34/100 is below the peer average of 66/100.

SY Revenue & Earnings Trend

In Q2 FY2026, SY generated $75.2M in top-line revenue, marking a sequential increase of 17.1%. The company recorded a net loss of $3.4M, with diluted EPS of $-0.03. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, SY averaged $-0.07 in diluted EPS.

Company Profile

So-Young International Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Beijing, CN. The company is led by CEO Xing Jin. SY has traded publicly since 2019.

SY Financials

Fundamental Snapshot

Revenue Growth (FY)
+1.0%
Net Income Growth (FY)
+60.0%
EPS Growth (FY)
+59.6%
Free Cash Flow Growth (FY)
-242.5%
Return on Equity (TTM)
-15.9%
Current Ratio
1.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Established platform with a significant user base.
  • Diverse range of services catering to various healthcare needs.
  • Strong gross margin indicating operational efficiency.
  • Upcoming: Expansion of service offerings into new healthcare segments.

Bear Case

  • Negative profit margin indicating current financial challenges.
  • Heavy reliance on the Chinese market for revenue.
  • Limited brand recognition outside of China.
  • Potential: Regulatory changes impacting the medical aesthetics industry.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $75M -$3M -$0.03
Q1 FY2026 $64M -$7M -$0.06
Q4 FY2025 $68M -$16M -$0.12
Q3 FY2025 $58M -$10M -$0.07

Q2 FY2026 · filed 31 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis · Converted to USD from CNY at today's rate

SY Latest News

SY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SY.

Price Targets

Wall Street price target analysis for SY.

SY MoonshotScore

34/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. SY scores 34/100 (Grade D): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Xing Jin

CEO

Xing Jin has extensive experience in the healthcare technology sector, having led So-Young International Inc. since its inception in 2013. With a strong background in business management and technology, he has been instrumental in the company's growth and innovation. Prior to founding So-Young, he held various leadership roles in technology and healthcare companies, contributing to his expertise in the field.

Track Record: Under Xing Jin's leadership, So-Young has grown its user base significantly and expanded its service offerings. He has successfully navigated the company through challenges in the competitive healthcare landscape, focusing on operational efficiency and user engagement.

So-Young International Inc. ADR Information Sponsored

An American Depositary Receipt (ADR) is a negotiable certificate issued by a U.S. bank representing a specific number of shares in a foreign company's stock. So-Young International Inc. operates as a Level II ADR, allowing U.S. investors to trade shares of the company on U.S. exchanges while maintaining its primary listing in China.

  • Home Market Ticker: The primary stock exchange for So-Young International Inc. is in Beijing, China.
  • ADR Level: 2
  • ADR Ratio: 1:1
Currency Risk: Investors in So-Young's ADR face currency risk as fluctuations in the exchange rate between the U.S. dollar and the Chinese yuan can affect the value of their investments. Changes in currency values can impact the returns on investment when converting profits back to U.S. dollars.
Tax Implications: As an ADR, So-Young's dividends, if any, would be subject to a foreign withholding tax rate, which can vary based on tax treaties between the U.S. and China. Investors should consult tax professionals regarding specific implications.
Trading Hours: The trading hours for the primary market in China differ from U.S. trading hours, which may affect liquidity and trading strategies for investors holding So-Young's ADRs.

Common Questions About SY (Healthcare)

What does the AI Score mean for SY?

SY holds an AI Score of 34/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is SY a good stock?

Stock Expert AI does not rate SY buy, sell or hold. So-Young International Inc. carries a MoonshotScore of 34/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What does So-Young International Inc. do?

So-Young International Inc. operates an online platform that connects users with medical aesthetic and healthcare service providers. The platform facilitates reservations for various treatments, provides valuable content and user experiences, and offers services such as Software as a Service and consulting for healthcare professionals.

What are the key factors to evaluate for SY?

So-Young International Inc. (SY) holds a MoonshotScore of 34/100 (low). So-Young International Inc. presents a unique investment thesis driven by its strong market position in the rapidly growing medical aesthetics sector. Not financial advice.

How frequently does SY data refresh on this page?

SY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven SY's recent stock price performance?

So-Young International Inc. (SY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established platform with a significant user base. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SY overvalued or undervalued right now?

So-Young International Inc. (SY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of SY?

Yes, most major brokerages offer fractional shares of So-Young International Inc. (SY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track SY's earnings and financial reports?

So-Young International Inc. (SY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for SY earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover